Thermo Fisher Scientific 미래 성장

Future 기준 확인 1/6

Thermo Fisher Scientific (는) 각각 연간 11.5% 및 5.7% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 11.6% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 17.4% 로 예상됩니다.

주요 정보

11.5%

수익 성장률

11.6%

EPS 성장률

Life Sciences 수익 성장	17.8%
매출 성장률	5.7%
향후 자기자본 수익률	17.4%
애널리스트 커버리지	Good
마지막 업데이트	20 Dec 2024

최근 미래 성장 업데이트

Thermo Fisher Scientific Inc. (NYSE:TMO) Just Released Its First-Quarter Earnings: Here's What Analysts Think

Apr 27

Here's What Analysts Are Forecasting For Thermo Fisher Scientific Inc. (NYSE:TMO) After Its Yearly Results

Feb 02

Recent updates

Thermo Fisher Scientific Q3: Expecting Market Recovery In FY25; Upgrade To 'Buy'

Oct 23

Thermo Fisher Scientific: Fantastic Company, Rich Valuation

Oct 04

These 4 Measures Indicate That Thermo Fisher Scientific (NYSE:TMO) Is Using Debt Reasonably Well

Sep 21

Thermo Fisher Scientific Inc.'s (NYSE:TMO) Price Is Out Of Tune With Earnings

Aug 16

Thermo Fisher Scientific: Microscopic Signs Of Growth Emerging

Jul 25

A Look At The Fair Value Of Thermo Fisher Scientific Inc. (NYSE:TMO)

Jul 11

Is Thermo Fisher Scientific (NYSE:TMO) A Risky Investment?

Jun 18

Low Yield, High Growth: Unveiling The Power Of Thermo Fisher's Dividends

Jun 07

Thermo Fisher: Renewed Growth Yet To Materialize, But Already Priced In (Rating Downgrade)

Apr 30

Thermo Fisher Scientific Inc. (NYSE:TMO) Just Released Its First-Quarter Earnings: Here's What Analysts Think

Apr 27

Why Thermo Fisher Scientific Inc. (NYSE:TMO) Could Be Worth Watching

Apr 24

Thermo Fisher Scientific: Too Hot To Handle

Apr 15

Investors Still Waiting For A Pull Back In Thermo Fisher Scientific Inc. (NYSE:TMO)

Apr 02

We Think Thermo Fisher Scientific (NYSE:TMO) Can Stay On Top Of Its Debt

Mar 12

Thermo Fisher's Bright Future Makes It A Great Buy On Weakness

Feb 06

Here's What Analysts Are Forecasting For Thermo Fisher Scientific Inc. (NYSE:TMO) After Its Yearly Results

Feb 02

Thermo Fisher: Blue Chip Stock Melded With Growth Characteristics

Jan 16

수익 및 매출 성장 예측

NYSE:TMO - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2026	48,296	8,069	9,501	10,835	24
12/31/2025	44,999	6,943	8,681	9,796	28
12/31/2024	42,812	6,143	6,941	8,214	28
9/28/2024	42,370	6,135	7,775	9,100	N/A
6/29/2024	42,346	6,220	7,963	9,348	N/A
3/30/2024	42,492	6,034	7,560	8,928	N/A
12/31/2023	42,857	5,995	6,927	8,406	N/A
9/30/2023	43,421	5,941	6,546	8,170	N/A
7/1/2023	43,524	5,721	5,854	7,693	N/A
4/1/2023	43,807	6,024	5,620	7,681	N/A
12/31/2022	44,915	6,950	6,911	9,154	N/A
10/1/2022	44,167	7,032	5,600	8,124	N/A
7/2/2022	42,820	7,439	6,336	8,837	N/A
4/2/2022	41,123	7,603	7,001	9,536	N/A
12/31/2021	39,211	7,725	6,789	9,312	N/A
10/2/2021	39,059	8,565	7,916	10,194	N/A
7/3/2021	38,250	8,596	8,132	10,252	N/A
4/3/2021	35,894	7,924	8,062	9,911	N/A
12/31/2020	32,218	6,375	6,815	8,289	N/A
9/26/2020	28,497	4,879	5,686	6,863	N/A
6/27/2020	26,248	3,706	4,245	5,272	N/A
3/28/2020	25,647	3,669	3,702	4,680	N/A
12/31/2019	25,542	3,696	4,047	4,973	N/A
9/28/2019	25,220	3,592	3,940	4,861	N/A
6/29/2019	24,868	3,541	4,086	4,964	N/A
3/30/2019	24,630	3,174	4,273	5,114	N/A
12/31/2018	24,358	2,938	3,785	4,543	N/A
9/29/2018	23,898	2,570	3,919	4,608	N/A
6/30/2018	23,094	2,395	N/A	4,317	N/A
3/31/2018	22,006	2,256	N/A	3,722	N/A
12/31/2017	20,918	2,228	N/A	4,005	N/A
9/30/2017	19,824	2,330	N/A	3,344	N/A
7/1/2017	19,199	2,270	N/A	3,220	N/A
4/1/2017	18,744	2,174	N/A	3,284	N/A
12/31/2016	18,274	2,025	N/A	3,258	N/A
10/1/2016	17,973	1,999	N/A	3,281	N/A
7/2/2016	17,606	2,003	N/A	3,220	N/A
4/2/2016	17,341	1,998	N/A	3,072	N/A
12/31/2015	16,965	1,980	N/A	2,942	N/A
9/26/2015	16,806	1,978	N/A	2,543	N/A
6/27/2015	16,854	1,971	N/A	2,475	N/A
3/28/2015	16,905	1,738	N/A	2,598	N/A
12/31/2014	16,890	1,896	N/A	2,620	N/A
9/27/2014	15,864	1,635	N/A	2,394	N/A
6/28/2014	14,884	1,482	N/A	2,224	N/A
3/29/2014	13,802	1,481	N/A	1,814	N/A
12/31/2013	13,090	1,279	N/A	2,011	N/A

애널리스트 미래 성장 예측

수입 대 저축률: TMO 의 연간 예상 수익 증가율( 11.5% )이 saving rate( 2.6% 보다 높습니다. ).

수익 vs 시장: TMO 의 연간 수익( 11.5% ) US 시장( 15.2% 보다 느리게 성장할 것으로 예상됩니다. 15.2% 연간).

고성장 수익: TMO 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.

수익 대 시장: TMO 의 수익(연간 5.7% ) US 시장( 9.2% 보다 느리게 성장할 것으로 예상됩니다. 9.2% 연간).

고성장 수익: TMO 의 수익(연간 5.7% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: TMO 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 17.4 %).

성장 기업 발견

기업 분석 및 재무 데이터 현황

데이터	마지막 업데이트(UTC 시간)
기업 분석	2024/12/30 03:33
장 마감 주가	2024/12/30 00:00
수익	2024/09/28
연간 수익	2023/12/31

데이터 소스

기업 분석에 사용된 데이터는 S&P Global Market Intelligence LLC의 데이터입니다. 이 보고서를 생성하기 위해 분석 모델에 사용된 데이터는 다음과 같습니다. 데이터는 정규화되어 있으므로 소스가 제공되기까지 지연이 발생할 수 있습니다.

패키지	데이터	기간	미국 소스 예시 ^*
회사 재무	10년	손익 계산서 현금 흐름표 대차 대조표	SEC 양식 10-K SEC 양식 10-Q
애널리스트 컨센서스 추정치	+3년	재무 예측 애널리스트 목표가	애널리스트 연구 보고서 Blue Matrix
시장 가격	30년	주식 가격 배당금, 분할 및 액션	ICE 시장 데이터 SEC 양식 S-1
소유권	10년	최대 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
관리	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발 사항	10년	회사 공지 사항	SEC 양식 8-K

* 미국 증권의 경우, 미국 외 지역의 규제 양식 및 출처가 사용된 예입니다.

명시되지 않는 한 모든 재무 데이터는 1년을 기준으로 하지만 분기별로 업데이트됩니다. 이를 후행 12개월(TTM) 또는 최근 12개월(LTM) 데이터라고 합니다. 여기에서 자세히 알아보세요.

분석 모델 및 눈송이

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 Github 페이지에서 확인할 수 있으며, 보고서 사용 방법에 대한 가이드와 튜토리얼도 유튜브에서 확인할 수 있습니다.

Simply 월스트리트 분석 모델을 설계하고 구축한 세계적인 수준의 팀에 대해 알아보세요.

산업 및 부문 메트릭

업계 및 섹션 지표는 Simply Wall St에서 6시간마다 계산되며, 자세한 내용은 확인할 수 있습니다.

애널리스트 출처

Thermo Fisher Scientific Inc. 55 애널리스트 중 28 애널리스트가 보고서의 입력 자료로 사용된 매출 또는 수익 추정치를 제출했습니다. 애널리스트의 제출 자료는 하루 종일 업데이트됩니다.

분석가	교육기관
Kadambari Daptardar	Accountability Research Corporation
David Toung	Argus Research Company
Catherine Ramsey Schulte	Baird

Thermo Fisher Scientific 미래 성장

Future 기준 확인 1/6

주요 정보

최근 미래 성장 업데이트

Thermo Fisher Scientific Inc. Provides Earnings Guidance for the Year 2024

Thermo Fisher Scientific Inc. Raises Earnings Guidance for the Year 2024

Thermo Fisher Scientific Inc. (NYSE:TMO) Just Released Its First-Quarter Earnings: Here's What Analysts Think

Thermo Fisher Scientific Inc. Raises Revenue Guidance for the Full Year 2024

Here's What Analysts Are Forecasting For Thermo Fisher Scientific Inc. (NYSE:TMO) After Its Yearly Results

Thermo Fisher Scientific Inc. Announces Earnings Guidance for Full Year 2024

Recent updates

Thermo Fisher Scientific Inc.'s (NYSE:TMO) Share Price Not Quite Adding Up

Thermo Fisher Scientific: Renewed Growth Momentum After The Pandemic

Upcoming dividend of US$0.39 per share

Thermo Fisher: M&A And Innovation To Drive Sales Growth

Thermo Fisher Scientific Launches CTS™ Detachable Dynabeads™ CD4 and CTS Detachable Dynabeads CD8 to Enhance Cell Therapy Development and Production

Chairman notifies of intention to sell stock

Thermo Fisher Scientific Inc. (NYSE:TMO) announces an Equity Buyback for $4,000 million worth of its shares.

Thermo Fisher Scientific: Near The Bottom And Attractively Valued

Third quarter dividend of US$0.39 announced

Thermo Fisher Scientific Inc. Declares Quarterly Cash Dividend, Payable on January 15, 2025

Senior VP & General Counsel notifies of intention to sell stock

Third quarter 2024 earnings: EPS exceeds analyst expectations

Thermo Fisher Scientific Q3: Expecting Market Recovery In FY25; Upgrade To 'Buy'

Thermo Fisher Scientific Inc. Provides Earnings Guidance for the Year 2024

Thermo Fisher Scientific Introduces Fully Integrated Multimodal Analytical Scanning Transmission Electron Microscope to Advance Novel Research in Materials Science

Thermo Fisher Scientific: Fantastic Company, Rich Valuation

Thermo Fisher Scientific Introduces Mass Spectrometers to Simplify Trace Elemental Analysis and Enhance Productivity

Thermo Fisher Scientific Inc. to Report Q3, 2024 Results on Oct 23, 2024

These 4 Measures Indicate That Thermo Fisher Scientific (NYSE:TMO) Is Using Debt Reasonably Well

Upcoming dividend of US$0.39 per share

Chairman notifies of intention to sell stock

Thermo Fisher Scientific Inc.'s (NYSE:TMO) Price Is Out Of Tune With Earnings

FDA Grants Thermo Fisher Scientific Inc.'s SeCore HLA Typing Kit 510(k) Clearance for Use as Companion Diagnostic with a T-Cell Receptor Therapy for Synovial Sarcoma

Chairman notifies of intention to sell stock

Thermo Fisher Scientific Inc. Announces Extended 510k Clearance of Freelite Assays for Evaluation of MGUS

Insider recently sold US$2.2m worth of stock

Insider notifies of intention to sell stock

Thermo Fisher Scientific Inc. Showcases Diagnostics Innovation Across Therapeutic Areas at ADLM 2024

Second quarter 2024 earnings: EPS exceeds analyst expectations

Thermo Fisher Scientific: Microscopic Signs Of Growth Emerging

Thermo Fisher Scientific Inc. Raises Earnings Guidance for the Year 2024

First quarter dividend of US$0.39 announced

Thermo Fisher Scientific to Help Advance Myeloid Cancer Clinical Research and Treatment Utilizing Next Generation Sequencing Technology

A Look At The Fair Value Of Thermo Fisher Scientific Inc. (NYSE:TMO)

Thermo Fisher Scientific Inc. (NYSE:TMO) completed the acquisition of Olink Holding AB (publ) (NasdaqGM:OLK) from Summa Equity AB and others.

Thermo Fisher Scientific Inc. to Report Q2, 2024 Results on Jul 24, 2024

Thermo Fisher Scientific Inc.(NYSE:TMO) dropped from Russell 1000 Growth-Defensive Index

Thermo Fisher Scientific Introduces the Only Fully Automated Plasmid Purification System to Help Accelerate Discovery and Development of Therapies

Is Thermo Fisher Scientific (NYSE:TMO) A Risky Investment?

Thermo Fisher Scientific Introduces Thermo Scientific Heracell VIOS 250i AxD CO2 Incubators

Upcoming dividend of US$0.39 per share

Low Yield, High Growth: Unveiling The Power Of Thermo Fisher's Dividends

Chairman notifies of intention to sell stock

Thermo Fisher Scientific Introduces Innovative Mass Spectrometer to Advance Clinical Research

Thermo Fisher Scientific Updates Chromosomal Microarray Analysis Solutions to Comply with IVDR Regulation

First quarter dividend of US$0.39 announced

Thermo Fisher Scientific Inc. Declares Quarterly Dividend, Payable on July 15, 2024

Thermo Fisher Scientific Introduces Array-Based Solution for Extended Blood Type Research to Support Future Advancements Toward Safer Transfusions

Senior VP & CFO notifies of intention to sell stock

Thermo Fisher: Renewed Growth Yet To Materialize, But Already Priced In (Rating Downgrade)

Senior VP & General Counsel notifies of intention to sell stock

Thermo Fisher Scientific Inc. (NYSE:TMO) Just Released Its First-Quarter Earnings: Here's What Analysts Think

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Thermo Fisher Scientific Inc. Raises Revenue Guidance for the Full Year 2024

Why Thermo Fisher Scientific Inc. (NYSE:TMO) Could Be Worth Watching

Thermo Fisher Scientific: Too Hot To Handle

Thermo Fisher Scientific Inc. Introduces Animal Origin-Free Formulation to Support Scaling of Cell Therapy Manufacturing

Thermo Fisher Scientific Inc., Annual General Meeting, May 22, 2024

Thermo Fisher Scientific Introduces Its Newest Line of High Performance, Ultra-Low Temperature (ULT) Freezers

Thermo Fisher Scientific Inc. to Report Q1, 2024 Results on Apr 24, 2024

Investors Still Waiting For A Pull Back In Thermo Fisher Scientific Inc. (NYSE:TMO)

Thermo Fisher Scientific Announces A New In-Line Metrology Solution to Improve Battery Safety and Performance

Chairman notifies of intention to sell stock

We Think Thermo Fisher Scientific (NYSE:TMO) Can Stay On Top Of Its Debt

Thermo Fisher Scientific Inc. Launches Corevitas Clinical Registry in Generalized Pustular Psoriasis

Upcoming dividend of US$0.39 per share

Chairman notifies of intention to sell stock

Fourth quarter dividend increased to US$0.39

Thermo Fisher Scientific Inc. Increases Quarterly Cash Dividend, Payable on April 15, 2024